Poxel Announces Drawdown of Additional Tranche D PDR Bonds Under Continuation Plan POXEL SA, a biopharmaceutical firm specializing in innovative therapies for serious chronic diseases with metabolic origins, including metabolic…
Ono Pharma Files Application in Japan for Ripretinib (DCC-2618) to Treat Advanced Gastrointestinal Stromal Tumors Ono Pharmaceutical, headquartered in Osaka, Japan, under the leadership of President Toichi Takino, has announced…
Element Science Earns Spot on Fast Company’s 2026 List of the World’s Most Innovative Companies Element Science has earned a place on Fast Company’s prestigious list of the World’s Most…
NBDF’s Pathway to Cures Launches Spark Biomedical’s LUNA Trial to Explore Non-Drug Treatment for Heavy Menstrual Bleeding For many women and adolescent girls living with inherited bleeding disorders, heavy menstrual…
Roseman University Establishes 120,000-Square-Foot Bioventures Hub in Las Vegas to Accelerate Life Science Innovation Roseman University of Health Sciences has officially launched Roseman Bioventures in Las Vegas, marking a significant…
U.S. Food and Drug Administration Approves Updated Label to Enable Faster Thawing of ADSTILADRIN® (nadofaragene firadenovec-vncg) Ferring Pharmaceuticals has announced that the U.S. Food and Drug Administration has approved an…
Medpace Holdings, Inc. Schedules Release of First Quarter 2026 Financial Results for April 22, 2026 Medpace Holdings has announced the upcoming release of its financial results for the first quarter…
Enhancing Digital Health Capabilities Through Integrated Blended Learning Approaches Across many low- and middle-income countries, the promise of digital health transformation is often constrained by a persistent and complex reality:…
Grifols Advances Plans to Launch IPO for Its U.S. Biopharma Division Grifols has taken a significant strategic step toward reshaping its corporate structure and accelerating long-term growth, as its Strategy…
WuXi Biologics Announces Record-Breaking Financial Performance for Fiscal Year 2025 WuXi Biologics has reported a year of strong financial performance and operational expansion for the fiscal year ending December 31,…
Celltrion Unveils KRW 1.2 Trillion Investment to Expand Drug Substance Manufacturing in Songdo, Boosting Total Capacity to 570,000 Liters Celltrion has unveiled an ambitious large-scale investment strategy exceeding KRW 1…
Alnylam Drives Innovation in ATTR-CM Care Through Strategic Collaboration with Viz.ai and Ongoing Support for the American Heart Association Alnylam Pharmaceuticals is spearheading a comprehensive, system-wide initiative aimed at transforming…